Inhalational Anthrax Due to Bioterrorism: Would Current Centers for Disease Control and Prevention Guidelines Have Identified the 11 Patients with Inhalational Anthrax from October through November 2001?

Mayer, Thom A.; Morrison, Allan; Bersoff-Matcha, Susan; Druckenbrod, Glenn; Murphy, Cecele; Howell, John; Hanfling, Dan; Cates, Robert; Pauze, Denis; Earls, James
May 2003
Clinical Infectious Diseases;5/15/2003, Vol. 36 Issue 10, p1275
Academic Journal
A panel of 10 physicians used the nominal group technique to assess the ability of the Centers for Disease Control and Prevention (CDC) interim guidelines for clinical evaluation of persons with possible inhalational anthrax (IA) to retrospectively identify the 11 patients with IA seen during the October 2001 bioterrorism outbreak. The guidelines would not have identified 10 of 11 of these patients, primarily because the guidelines were designed to address only those patients with a known history of exposure or clearly identified environmental or occupational risk. The panel suggested revisions to the guidelines, primarily consisting of broadening the criteria for evaluation to include either known exposure or environmental occupational risk, or to include clinical symptoms consistent with IA. These extensions of the guidelines retrospectively identified 8 of 11 of the patients with IA from October 2001.


Related Articles

  • HHS, CDC push importance of anthrax symptom recognition among doctors. Parker, Che // AHA News;10/29/2001, Vol. 37 Issue 43, p1 

    Reports on the contention of the United States Centers for Disease Control and Prevention about the importance of delivering information on anthrax-related symptoms to practicing doctors. Purpose of delivering such information to doctors; Incident leading to the issuance of the statement; Best...

  • Update: Investigation of Bioterrorism-Related Anthrax and Adverse Events from Antimicrobial Prophylaxis.  // MMWR: Morbidity & Mortality Weekly Report;Nov2001, Vol. 50 Issue 44, p973 

    Presents updates on the investigation of bioterrorism-associated anthrax cases in the United States (U.S.) as of November 2001. Information on anthrax cases identified according to the U.S. Center for Disease Control surveillance case definition; Adverse events from antimicrobial prophylaxis;...

  • Bioterrorism-Related Anthrax: International Response by the Centers for Disease Control and Prevention. Polyak, Christina S.; Macy, Jonathan T.; Irizarry-De La Cruz, Margarita; Lai, James E.; McAuliffe, Jay F.; Popovic, Tanja; Pillai, Segaran P.; Mintz, Eric D. // Emerging Infectious Diseases;Oct2002, Vol. 8 Issue 10, p1056 

    Describes the international response of the U.S. Centers for Disease Control and Prevention (CDC) to bioterrorism-related anthrax. Function of the international team established by the CDC in response to anthrax bioterrorism; Level of support provided by the team to various countries for...

  • Confusion in Spades. Spake, Amanda; Boyce, Nell; Hawkins, Dana; Schultz, Stacey; Sobel, Rachel K. // U.S. News & World Report;10/29/2001, Vol. 131 Issue 18, p42 

    Reports on fears of anthrax exposure and infection in the United States following the mailing of letters containing anthrax to various locations. Preparedness of the public-health system in the United States for a biological weapons attack; Views from the U.S. Centers for Disease Control...

  • National security and the lab. Atlas, Ronald // MLO: Medical Laboratory Observer;Sep2003, Vol. 35 Issue 9, p52 

    Focuses on the impact of anthrax attacks on U.S. laboratories. Support of the American Society for Microbiology (ASM) for the development of measures to reduce the threat of catastrophic acts of bioterrorism; Development of protocols for diagnostic laboratories by the ASM and Centers for...

  • Update: Investigation of Bioterrorism-Related Anthrax and Interim Guidelines for Clinical Evaluations of Persons with Possible Anthrax.  // MMWR: Morbidity & Mortality Weekly Report;11/2/2001, Vol. 50 Issue 43, p941 

    Presents an update of an investigation conducted by the United States Centers for Disease Control and Prevention on cases of bioterrorism-related anthrax as of October 31, 2001. Evaluation of interim guidelines for clinical screening of persons with possible anthrax; Incidence of inhalational...

  • Update: Investigation of Bioterrorism-Related Anthrax--Connecticut, 2001. Lustig, N.; Spargo, K.; Carver, W.; Cartter, M.; Garcia, J.; Barden, D.M.; Mayo, D.R.; Kelley, K.A.; Hadler, J.; DiFerdinando, G.; Bresnitz, E.; Hathcock, L. // JAMA: Journal of the American Medical Association;1/2/2002, Vol. 287 Issue 1, p34 

    Revises the number of suspected bioterrorism-related anthrax cases in the United States and updates the investigation of the death of an elderly woman in Connecticut from inhalational anthrax. Prospective health surveillance which includes asking community organizations to report persons with...

  • Call-Tracking Data and the Public Health Response to Bioterrorism-Related Anthrax. Mott, Joshua A.; Treadwell, Tracee A.; Hennessy, Thomas W.; Rosenberg, Paula A.; Wolfe, Mitchell I.; Brown, Clive M.; Butler, Jay C. // Emerging Infectious Diseases;Oct2002, Vol. 8 Issue 10, p1088 

    Focuses on the facilitation of call-tracking data by the Emergency Operations Center (EOC) of the U.S. Centers for Disease Control and Prevention in response to bioterrorism-related anthrax cases. Description of the EOC telephone call triage system; Recommendation of changes in the triage...

  • Collaboration between Public Health and Law Enforcement: New Paradigms and Partnerships for Bioterrorism Planning and Response. Butler, Jay C.; Cohen, Mitchell L.; Friedman, Cindy R.; Scripp, Robert M.; Waltz, Craig G. // Emerging Infectious Diseases;Oct2002, Vol. 8 Issue 10, p1152 

    Describes the collaborations between the U.S. Centers for Disease Control and Prevention and the Federal Bureau of Investigation during the investigation of a possible anthrax bioterrorism outbreak in 2001. Flow of communication during overt bioterrorism in most and some jurisdictions;...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics